Cargando…
Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy
FKBP51 (FK506-binding protein 51) is a known co-chaperone and regulator of the glucocorticoid receptor (GR), which usually attenuates its activity. FKBP51 is one of the major GR target genes in skin, but its role in clinical effects of glucocorticoids is not known. Here, we used FKBP51 knockout (KO)...
Autores principales: | Baida, Gleb, Bhalla, Pankaj, Yemelyanov, Alexander, Stechschulte, Lance A., Shou, Weinian, Readhead, Ben, Dudley, Joel T., Sánchez, Edwin R., Budunova, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205168/ https://www.ncbi.nlm.nih.gov/pubmed/30410676 http://dx.doi.org/10.18632/oncotarget.26194 |
Ejemplares similares
-
Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014) -
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin
por: Klopot, Anna, et al.
Publicado: (2015) -
Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin
por: Baida, Gleb, et al.
Publicado: (2020) -
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
por: Baida, Gleb, et al.
Publicado: (2015) -
PI3K inhibitors protect against glucocorticoid-induced skin atrophy
por: Agarwal, Shivani, et al.
Publicado: (2019)